3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
35
Neoplasm Metastasis
7
Ovarian Neoplasms
6
Sarcoma
4
Neoplasms
4
Lymphoma, Non-Hodgkin
4
Pancreatic Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Glioma
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Wilms Tumor
2
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Neoplasms by Site
2
Medulloblastoma
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Liposarcoma
2
Leukemia, Myeloid, Acute
2
Histiocytosis, Langerhans-Cell
2
Interventions
tucatinib
1
pertuzumab
1
atezolizumab
1
Trastuzumab
1
Fulvestrant
1
Alpelisib
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HER2-positive Metastatic Breast Cancer
×
palbociclib
×
90 days
×
Clear all
No trials found.